Sign in to view content

Regulation of Epithelial-Mesenchymal Transition via RUNX1 in Proliferative Vitreoretinopathy

Leo A. Kim, MD, PhD

Video
Published 2019

Related

Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023
Postoperative Intravitreal Methotrexate Injections Reduce Reoperations in Eyes With Proliferative Vitreoretinopathy and Diabetic Retinopathy
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2021
Rho-kinase Inhibition on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy
Leo A. Kim, MD, PhD
Annual Meeting Talks
2021

Category: Retinal Detachment

See more